Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Other Accumulated Expenses (2022 - 2026)

Core Laboratories filings provide 5 years of Other Accumulated Expenses readings, the most recent being $17.4 million for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 279.32% to $17.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $17.4 million, a 279.32% increase, with the full-year FY2025 number at $4.3 million, down 47.63% from a year prior.
  • Other Accumulated Expenses hit $17.4 million in Q1 2026 for Core Laboratories, up from $4.3 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $17.4 million in Q1 2026 to a low of $3.2 million in Q3 2023.
  • Median Other Accumulated Expenses over the past 5 years was $4.8 million (2022), compared with a mean of $6.6 million.
  • Biggest five-year swings in Other Accumulated Expenses: plummeted 57.82% in 2025 and later soared 279.32% in 2026.
  • Core Laboratories' Other Accumulated Expenses stood at $4.8 million in 2022, then soared by 58.67% to $7.7 million in 2023, then grew by 6.61% to $8.2 million in 2024, then crashed by 47.63% to $4.3 million in 2025, then surged by 306.67% to $17.4 million in 2026.
  • The last three reported values for Other Accumulated Expenses were $17.4 million (Q1 2026), $4.3 million (Q4 2025), and $3.9 million (Q3 2025) per Business Quant data.